Real-world therapeutic performance of pirfenidone for connective tissue disease-associated interstitial lung diseases

Real-world therapeutic performance of pirfenidone for connective tissue disease-associated interstitial lung diseases

Background: Pirfenidone (PFD) is commonly applied for antifibrotic treatment in patients with idiopathic pulmonary fibrosis but has rarely been studied in cases with connective tissue disease-associated interstitial lung diseases (CTD-ILDs). Objectives: We aimed to examine the efficacy of PFD in pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Xueting Yuan, Chen Yu, Shengyun Liu, Qiang Shu, Xinwang Duan, Lin Tang, Liying Peng, Shuang Zhou, Chanyuan Wu, Jiuliang Zhao, Dong Xu, Lan Song, Hui Huang, Mengtao Li, Yanhong Wang, Qian Wang, Xiaofeng Zeng
Format: Article
Language:English
Published: SAGE Publishing 2024-11-01
Series:Therapeutic Advances in Respiratory Disease
Online Access:https://doi.org/10.1177/17534666241292507
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/17534666241292507

Similar Items